Volume 65, Issue 3, Pages (March 2004)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 4, Pages (October 2004)
Advertisements

Increased expression of heparanase in overt diabetic nephropathy
Antioxidant Treatment Prevents Renal Damage and Dysfunction and Reduces Arterial Pressure in Salt-Sensitive Hypertension by Niu Tian, Kristina D. Thrasher,
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Differential Effects of Angiotensin II Type-1 Receptor Antisense Oligonucleotides on Renal Function in Spontaneously Hypertensive Rats by Minoru Yoneda,
Volume 65, Issue 1, Pages (January 2004)
Volume 58, Issue 4, Pages (October 2000)
Volume 58, Issue 1, Pages (July 2000)
Volume 84, Issue 5, Pages (November 2013)
Volume 69, Issue 9, Pages (May 2006)
Volume 80, Issue 6, Pages (September 2011)
Altered microRNA expression in stenoses of native arteriovenous fistulas in hemodialysis patients  Lei Lv, MD, Weibin Huang, MD, Jiwei Zhang, MD, Yaxue.
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Critical role for osteopontin in diabetic nephropathy
Volume 71, Issue 10, Pages (May 2007)
Volume 68, Issue 2, Pages (August 2005)
Volume 65, Issue 5, Pages (May 2004)
Volume 65, Issue 4, Pages (April 2004)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 58, Issue 6, Pages (December 2000)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
John Keeling, Guillermo A. Herrera  Kidney International 
Volume 56, Issue 3, Pages (September 1999)
Volume 61, Issue 1, Pages (January 2002)
Volume 70, Issue 2, Pages (July 2006)
Volume 57, Issue 3, Pages (March 2000)
The intrarenal renin-angiotensin system in hypertension
Hiroyuki Kobori, Lisa M. Harrison-Bernard, L. Gabriel Navar 
Volume 59, Issue 5, Pages (May 2001)
Volume 59, Issue 4, Pages (April 2001)
Evidence for low-density lipoprotein–induced expression of connective tissue growth factor in mesangial cells  Mimi Sohn, Yan Tan, Richard L. Klein, Ayad.
Autophagy in proximal tubules protects against acute kidney injury
F. Yi, A.Y. Zhang, N. Li, R.W. Muh, M. Fillet, A.-F. Renert, P.-L. Li 
Volume 67, Issue 3, Pages (March 2005)
Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery  Vicente Orozco-Sevilla, MD,
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 87, Issue 2, Pages (February 2015)
Down-regulation of Na+ transporters and AQP2 is responsible for acyclovir-induced polyuria and hypophosphatemia  Lúcia Andrade, Nancy A. Rebouças, Antonio.
Lori L. Woods, Douglas A. Weeks, Ruth Rasch  Kidney International 
Volume 67, Issue 5, Pages (May 2005)
Volume 63, Issue 2, Pages (February 2003)
Volume 57, Issue 1, Pages (January 2000)
Volume 62, Issue 2, Pages (August 2002)
Volume 83, Issue 3, Pages (March 2013)
17-β Estradiol attenuates streptozotocin-induced diabetes and regulates the expression of renal sodium transporters  S. Riazi, C. Maric, C.A. Ecelbarger 
Volume 61, Issue 6, Pages (June 2002)
Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis  J. Mahmood, F. Khan, S. Okada,
Volume 53, Issue 5, Pages (May 1998)
Volume 66, Issue 4, Pages (October 2004)
Volume 66, Issue 5, Pages (November 2004)
Volume 70, Issue 10, Pages (November 2006)
Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells  Z. Su, J. Zimpelmann, K.D. Burns  Kidney.
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 82, Issue 3, Pages (August 2012)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 61, Issue 3, Pages (March 2002)
Volume 55, Issue 3, Pages (March 1999)
LncRNA ZEB1-AS1 Was Suppressed by p53 for Renal Fibrosis in Diabetic Nephropathy  Juan Wang, Jian Pang, Huiling Li, Jie Long, Fang Fang, Junxiang Chen,
Volume 69, Issue 11, Pages (June 2006)
Lipid-binding proteins in rat and human kidney
Volume 54, Pages S189-S191 (September 1998)
Renal phenotype of low kallikrein rats
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats
AT1a receptor knockout in mice impairs urine concentration by reducing basal vasopressin levels and its receptor signaling proteins in the inner medulla 
Volume 58, Issue 3, Pages (September 2000)
Volume 58, Issue 6, Pages (December 2000)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 70, Issue 1, Pages (July 2006)
Presentation transcript:

Volume 65, Issue 3, Pages 972-981 (March 2004) Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats  Akira Nishiyama, Masanori Yoshizumi, Matlubur Rahman, Hiroyuki Kobori, Dale M. Seth, Akira Miyatake, Guo-Xing Zhang, L.I. Yao, Hirofumi Hitomi, Takatomi Shokoji, Hideyasu Kiyomoto, Shoji Kimura, Toshiaki Tamaki, Masakazu Kohno, Youichi Abe  Kidney International  Volume 65, Issue 3, Pages 972-981 (March 2004) DOI: 10.1111/j.1523-1755.2004.00476.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 (A) Mean blood pressure (MBP) profile in Dahl rats at 0, 1, 2, 3, and 4weeks. *P < 0.05 vs. baseline. †P < 0.05 vs. DS/L rats. (B) Urinary protein excretion in Dahl rats at 4weeks. MBP and urinary protein excretions in DS/H rats were significantly higher than those in DS/L, DR/H, and DR/L rats. Candesartan treatment did not alter MBP but significantly decreased urinary protein excretion in DS/H rats. *P < 0.05 vs. DS/L rats. DR/L rats: Dahl salt-resistant rats fed a 0.3% NaCl diet; DR/H rats: Dahl salt-resistant rats fed an 8% NaCl diet; DS/L rats: Dahl salt-sensitive rats fed 0.3% NaCl diet; DS/H rats: Dahl salt-sensitive rats fed an 8% NaCl diet; C: candesartan. Kidney International 2004 65, 972-981DOI: (10.1111/j.1523-1755.2004.00476.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Photomicrographs of glomeruli in Dahl rats. (A), Azan stain, and (B), HE stain, original magnification ×400, respectively. Glomerular scores of (C) glomerular matrix expansion and (D) proliferation. A minimum of 50 glomeruli was examined in each specimen. DS/H rats exhibited severely damaged glomeruli characterized by mesangial matrix expansion and cell proliferation. Candesartan markedly ameliorated these glomerular changes in DS/H rats. *P < 0.05 vs. DS/L rats. DR/L rats: Dahl salt-resistant rats fed a 0.3% NaCl diet; DR/H rats: Dahl salt-resistant rats fed an 8% NaCl diet; DS/L rats: Dahl salt-sensitive rats fed a 0.3% NaCl diet; DS/H rats: Dahl salt-sensitive rats fed an 8% NaCl diet. HE, hematoxylin-eosin; C, candesartan. Kidney International 2004 65, 972-981DOI: (10.1111/j.1523-1755.2004.00476.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Plasma angiotensin II concentrations (A and B) and kidney angiotensin II contents (C and D) in Dahl rats. Plasma angiotensin II levels were reduced by a high salt diet in both DR and DS rats. DR/H rats showed significantly lower kidney angiotensin II contents compared with those of DR rats fed a low salt diet. However, a high salt diet did not reduce the kidney angiotensin II contents in DS rats. Candesartan treatment increased the plasma angiotensin II concentrations, but markedly decreased kidney angiotensin II contents in DS/H rats. *P < 0.05 vs. the same strain on a low salt diet. †P < 0.05: DR/H rats vs. DR/H + candesartan rats, or DS/H rats vs. DS/H + candesartan rats. DR rats, Dahl salt-resistant rats; DS rats, Dahl salt-sensitive rats; C, candesartan. Kidney International 2004 65, 972-981DOI: (10.1111/j.1523-1755.2004.00476.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Renal cortical (A) angiotensin II type 1 receptor AT1 and (B) AT2 receptor protein levels in Dahl rats. All values were normalized by arbitrarily setting the densitometry of DS/L rats to 1.0. DR rats fed a high salt diet showed significantly reduced cortical tissue AT1 receptor protein levels compared with DR/L rats. However, cortical tissue AT1 receptor levels in DS rats were unaffected by a high salt diet. On the other hand, cortical tissue AT2 receptor levels were significantly increased in DS/H rats. As a control study to check for equal loading, membranes were reprobed with an antibody against β-actin. The results showed that the densitometric values were unaltered among the groups (data not shown). *P < 0.05 vs. the same strain on a low salt diet. DR rats, Dahl salt-resistant rats; DS rats, Dahl salt-sensitive rats. Kidney International 2004 65, 972-981DOI: (10.1111/j.1523-1755.2004.00476.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Renal cortical mitogen-activated protein kinases (MAPKs) activities in Dahl salt-sensitive (DS) rats. Renal cortical tissues were harvested, lysed, and used for subsequent analyses. The activities of (A) extracellular signal-regulated kinases (ERK) 1/2, (B) c-Jun NH2-terminal kinases (JNK), (C) p38 MAPK, and (D) Big MAPK-1 (BMK1) were measured as described in Methods. All values were normalized by arbitrarily setting the densitometry of DS/L rats to 1.0. Densitometric analysis of the immunoreactive bands showed that a high salt diet markedly increased renal cortical ERK1/2, JNK, and BMK1 activities in DS rats, whereas p38 MAPK activity was unchanged. Candesartan (C) treatment significantly reduced ERK1/2, JNK, and BMK1 activities by -45%, -60%, and -70%, respectively, in DS rats. On the other hand, no differences in the amounts of ERK1/2, JNK, p38 MAPK, and BMK1 were observed in samples by Western blotting analyses using pan-ERK1/2, JNK, p38 MAPK, and BMK1 (ERK5) antibodies (data not shown). Kidney International 2004 65, 972-981DOI: (10.1111/j.1523-1755.2004.00476.x) Copyright © 2004 International Society of Nephrology Terms and Conditions